Browsing by Author "Eralp, Y."

Now showing 1 - 3 of 3

Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey
(2019-01-01) Kilickap, S.; Demirci, U.; Bugdayci, F.; Tural, D.; Korkmaz, T.; Paydas, S.; Yilmaz, C.; Turna, H.; Sezer, A.; Cinkir, H. Yesil; Okutur, K.; Erman, M.; Eralp, Y.; Cabuk, D.; Isikdogan, A.; Demirkazik, A.; Karaoglu, A.; Yazilitas, D.; Senler, F. Cay; Yumuk, P. F.; Coskun, H.; Yildiz, I.; Oztop, I.; Beypinar, I.; Aydin, K.; Kaplan, M.; Meydan, N.; Olmez, O. F.; Ozyilkan, O.; Seber, S.; Arslan, C.; Sendur, M. A.; Cicin, I.
Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)
(2022-01-01) Orer, H. S.; Nomak, G.; Oksuzoglu, B.; Senturk, R.; Eralp, Y.; Yumuk, F.; Nomak, H.; Sanyal, R.
The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study
(2019-01-01) Eralp, Y.; Ak, N.; Yilmazbayhan, D.; Ozkan, B.; Ferhatoglu, F.; Demirkazik, A.; Sak, S. Dizbay; Dilege, S.; Tanju, S.; Toker, A.; Bulutay, P.; Firat, P.; Mandel, N. Molinas; Kilickap, S.; Onder, S.; Dikmen, E.; Alan, O.; Yumuk, P. F.; Bozkurtlar, E.; Lacin, T.; Ozturk, A.; Kocaturk, C.; Karapinar, K.; Urer, N.; Uluc, B. Oyan